This is an open-label study to evaluate the long term safety and effectiveness of oral treatment with BCX7353 in preventing acute angioedema attacks in patients with Type I and Type II HAE.
|Clinical Study Identifier||NCT03472040|
|Last Modified on||23 December 2020|
Select a piece of text and start making personal notes.
Congrats! You have your own personal workspace now.